Market Overview

Benzinga's Top Pre-Market Gainers

Share:
Related MNKD
Jefferies Expects Exciting 2015 For MannKind
JPM Securities Picks Through Biotech News For Winners
Orgenesis is Leading the Paradigm Shift in Diabetes Treatments (NVO, ORGS, MNKD) (Small Cap Network)
Related BRCD
Morgan Stanley, Oppenheimer Analysts Shrug Off Brocade Beat
Why This JP Morgan Analyst Is Watching T-Mobile, Hewlett-Packard And Others Today
Brocade +3.8% after Avago strikes deal to buy Emulex (Seeking Alpha)

MannKind (NASDAQ: MNKD) moved up 17.35% to $8.05 in the pre-market session after the company reported positive clinical data for AFREZZA.

Brocade Communications (NASDAQ: BRCD) soared 14.49% to $7.90 in the pre-market trading after the company reported better-than-expected fiscal third-quarter results.

Osiris Therapeutics (NASDAQ: OSIR) surged 9% to $27.73 in the pre-market session on clinical study results.

GenMark Diagnostics (NASDAQ: GNMK) shares gained 4.65% to $10.35 in the pre-market session after the company priced 7.6 million shares of common stock at $9.84.

Posted-In: Top Pre-Market GainersNews Pre-Market Outlook Markets Movers

 

Related Articles (BRCD + GNMK)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→